These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 10330424)
1. Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor. Chen Z; Saffitz JE; Latour MA; Schonfeld G J Clin Invest; 1999 May; 103(10):1419-30. PubMed ID: 10330424 [TBL] [Abstract][Full Text] [Related]
2. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908 [TBL] [Abstract][Full Text] [Related]
3. Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. Niemeier A; Willnow T; Dieplinger H; Jacobsen C; Meyer N; Hilpert J; Beisiegel U Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):552-61. PubMed ID: 10073957 [TBL] [Abstract][Full Text] [Related]
4. Interaction of LpB, LpB:E, LpB:C-III, and LpB:C-III:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Agnani G; Bard JM; Candelier L; Delattre S; Fruchart JC; Clavey V Arterioscler Thromb; 1991; 11(4):1021-9. PubMed ID: 2065026 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor. Young SG; Peralta FP; Dubois BW; Curtiss LK; Boyles JK; Witztum JL J Biol Chem; 1987 Dec; 262(34):16604-11. PubMed ID: 3680266 [TBL] [Abstract][Full Text] [Related]
6. Glycoprotein 330/low density lipoprotein receptor-related protein-2 mediates endocytosis of low density lipoproteins via interaction with apolipoprotein B100. Stefansson S; Chappell DA; Argraves KM; Strickland DK; Argraves WS J Biol Chem; 1995 Aug; 270(33):19417-21. PubMed ID: 7642623 [TBL] [Abstract][Full Text] [Related]
7. [Interaction between LDL receptor and lipoproteins containing apo B]. Clavey V; Agnani G; Bard JM; Lestavel-Delattre S; Fruchart JC Ann Endocrinol (Paris); 1991; 52(6):459-63. PubMed ID: 1824499 [TBL] [Abstract][Full Text] [Related]
8. Identification of the second cluster of ligand-binding repeats in megalin as a site for receptor-ligand interactions. Orlando RA; Exner M; Czekay RP; Yamazaki H; Saito A; Ullrich R; Kerjaschki D; Farquhar MG Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2368-73. PubMed ID: 9122201 [TBL] [Abstract][Full Text] [Related]
9. Cytosolic adaptor protein Dab2 is an intracellular ligand of endocytic receptor gp600/megalin. Oleinikov AV; Zhao J; Makker SP Biochem J; 2000 May; 347 Pt 3(Pt 3):613-21. PubMed ID: 10769163 [TBL] [Abstract][Full Text] [Related]
10. The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B. Zawadzki Z; Tercé F; Seman LJ; Theolis RT; Breckenridge WC; Milne RW; Marcel YL Biochemistry; 1988 Nov; 27(22):8474-81. PubMed ID: 2468359 [TBL] [Abstract][Full Text] [Related]
11. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100. Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979 [TBL] [Abstract][Full Text] [Related]
12. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Gabel BR; Koschinsky ML Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051 [TBL] [Abstract][Full Text] [Related]
13. Megalin-mediated endocytosis of transcobalamin-vitamin-B12 complexes suggests a role of the receptor in vitamin-B12 homeostasis. Moestrup SK; Birn H; Fischer PB; Petersen CM; Verroust PJ; Sim RB; Christensen EI; Nexø E Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8612-7. PubMed ID: 8710919 [TBL] [Abstract][Full Text] [Related]
14. [Conformation of apolipoprotein B-100--structure and functional classification of low density lipoproteins]. Titov VN Biokhimiia; 1996 Jan; 61(1):3-23. PubMed ID: 8679776 [TBL] [Abstract][Full Text] [Related]
15. Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs. Moestrup SK; Cui S; Vorum H; Bregengård C; Bjørn SE; Norris K; Gliemann J; Christensen EI J Clin Invest; 1995 Sep; 96(3):1404-13. PubMed ID: 7544804 [TBL] [Abstract][Full Text] [Related]
16. Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100. Corsini A; Mazzotti M; Villa A; Maggi FM; Bernini F; Romano L; Romano C; Fumagalli R; Catapano AL Atherosclerosis; 1992 Mar; 93(1-2):95-103. PubMed ID: 1596308 [TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [TBL] [Abstract][Full Text] [Related]
18. Conformationally specific enhancement of receptor-mediated LDL binding and internalization by peptide models of a conserved anionic N-terminal domain of human apolipoprotein E. Braddock DT; Mercurius KO; Subramanian RM; Dominguez SR; Davies PF; Meredith SC Biochemistry; 1996 Nov; 35(44):13975-84. PubMed ID: 8909295 [TBL] [Abstract][Full Text] [Related]
19. Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Saito A; Yamazaki H; Rader K; Nakatani A; Ullrich R; Kerjaschki D; Orlando RA; Farquhar MG Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8601-5. PubMed ID: 8710917 [TBL] [Abstract][Full Text] [Related]